Matches in Nanopublications for { ?s ?p "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP524634.RAcRENdYHpKqCGhTA_6lZAfwU9_UVf5woAVArv7oh9aq8130_assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524634.RAcRENdYHpKqCGhTA_6lZAfwU9_UVf5woAVArv7oh9aq8130_provenance.
- NP753803.RAN3h7VOG-YTwQfeJuFdgLV5ZPCFDhyorGOU60ALpGrYI130_assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753803.RAN3h7VOG-YTwQfeJuFdgLV5ZPCFDhyorGOU60ALpGrYI130_provenance.
- NP303871.RAxjnFNG3BnP7xZkMseruAtVUVtvzPz6iRjMCtO9rAmwo130_assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303871.RAxjnFNG3BnP7xZkMseruAtVUVtvzPz6iRjMCtO9rAmwo130_provenance.
- NP691106.RAXg4DnkyAtGAe1Y_CN0UKwHmH1wivZwzItVY8PgKimMg130_assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691106.RAXg4DnkyAtGAe1Y_CN0UKwHmH1wivZwzItVY8PgKimMg130_provenance.
- assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1061908.RAjz7Xh4pCnQRyKXgU6_gpEpT9kurMURHqAtYbpyH5Fng130_assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1061908.RAjz7Xh4pCnQRyKXgU6_gpEpT9kurMURHqAtYbpyH5Fng130_provenance.
- NP1061909.RAlbjz_eN8yuQEh08LUyT0jbKMb0FowoGKG76xUwJbL3E130_assertion description "[GiPSCs and their differentiating derivatives display widespread resetting of common GBM-associated changes, such as DNA hypermethylation of promoter regions of the cell motility regulator TES (testis-derived transcript), the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C; p57KIP2), and many polycomb-repressive complex 2 (PRC2) target genes (e.g., SFRP2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1061909.RAlbjz_eN8yuQEh08LUyT0jbKMb0FowoGKG76xUwJbL3E130_provenance.